E-LIB Suche - Ergebnisse für: Bavendam, T.

1

DEVELOPMENT AND VALIDATION OF A SELF-REPORTED MEASURE FOR U..:

Dielubanza, E ; Zincavage, R ; Maurao, M...
Continence. 7 (2023) - p. 100874 , 2023

Link: https://doi.org/10.1016/..

2

132 Evolution of BPH Healthcare Costs: 2004-2013:

Bajic, P. ; Wegrzyn, G. ; Nelson, M....
The Journal of Sexual Medicine. 17 (2020) Supplement_1 - p. S37-S37 , 2020

Link: https://doi.org/10.1016/..

3

Validation study of the Self-Assessment Goal Achievement (S..:

Brubaker, L. ; Piault, E. C. ; Tully, S. E....
International Journal of Clinical Practice. 67 (2013) 4 - p. 342-350 , 2013

Link: https://doi.org/10.1111/..

4

Antimuscarinics for treatment of storage lower urinary trac..:

Kaplan, S. A. ; Roehrborn, C. G. ; Abrams, P....
International Journal of Clinical Practice. 65 (2011) 4 - p. 487-507 , 2011

Link: https://doi.org/10.1111/..

5

Validation of a 3-item OAB awareness tool:

Coyne, K. S. ; Margolis, M. K. ; Bavendam, T...
International Journal of Clinical Practice. 65 (2011) 2 - p. 219-224 , 2011

Link: https://doi.org/10.1111/..

6

PUK21 PATIENT CHARACTERISTICS ASSOCIATED WITH INITIATION OF..:

Botros, S. ; Chen, C.I. ; Bavendam, T....
Value in Health. 14 (2011) 3 - p. A78 , 2011

Link: https://doi.org/10.1016/..

7

PUK5 TREATMENT PATTERNS IN OVERACTIVE BLADDER: REAL-WORLD P..:

Ellsworth, P. ; Bavendam, T. ; Zou, K.H...
Value in Health. 14 (2011) 3 - p. A75 , 2011

Link: https://doi.org/10.1016/..

8

PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIM..:

Verheggen, BG ; Lee, R ; Treur, MJ...
Value in Health. 12 (2009) 3 - p. A199 , 2009

Link: https://doi.org/10.1016/..

9

FESOTERODINE SIGNIFICANTLY IMPROVES TREATMENT RESPONSE RATE..:

Tubaro, A. ; Staskin, D. ; Nitti, V....
European Urology Supplements. 7 (2008) 3 - p. 239 , 2008

Link: https://doi.org/10.1016/..

10

1007 EFFECTS OF TOLTERODINE EXTENDED RELEASE AND/OR TAMSULO..:

Kaplan, S.A. ; Rovner, E.S. ; Sussman, P.O....
European Urology Supplements. 6 (2007) 2 - p. 274 , 2007

Link: https://doi.org/10.1016/..

11

MP-20.24: Tolterodine extended release (TER) and/or Tamsulo..:

Roehrborn, C.G. ; Kaplan, S.A. ; Jones, J.S....
Urology. 70 (2007) 3 - p. 158-159 , 2007

Link: https://doi.org/10.1016/..

12

MP-20.23: Tolterodine extended release (TER) and/or Tamsulo..:

Roehrborn, C.G. ; Kaplan, S.A. ; Kraus, S.R....
Urology. 70 (2007) 3 - p. 157-158 , 2007

Link: https://doi.org/10.1016/..

13

Efficacy of tolterodine extended release (TER) for patient-..:

Bachmann, G. ; Wang, J.T. ; Morrow, J.D..
Fertility and Sterility. 88 (2007) - p. S248-S249 , 2007

Link: https://doi.org/10.1016/..

14

Sexual function and satisfaction in heterosexual couples wh..:

Heiman, JR ; Talley, DR ; Bailen, JL...
BJOG: An International Journal of Obstetrics & Gynaecology. 114 (2007) 4 - p. 437-447 , 2007

Link: https://doi.org/10.1111/..

15

Tolterodine extended release improves patient-reported outc..:

ROBERTS, R. ; BAVENDAM, T. ; GLASSER, D. B....
International Journal of Clinical Practice. 60 (2006) 6 - p. 752-758 , 2006

Link: https://doi.org/10.1111/..